Generation of a chemical genetic model for JAK3
Abstract Janus Kinases (JAKs) have emerged as an important drug target for the treatment of a number of immune disorders due to the central role that they play in cytokine signalling. 4 isoforms of JAKs exist in mammalian cells and the ideal isoform profile of a JAK inhibitor has been the subject of...
Guardado en:
Autores principales: | Judit Remenyi, Rangeetha Jayaprakash Naik, Jinhua Wang, Momchil Razsolkov, Alyssa Verano, Quan Cai, Li Tan, Rachel Toth, Samantha Raggett, Carla Baillie, Ryan Traynor, C. James Hastie, Nathanael S. Gray, J. Simon C. Arthur |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/66b7f58af7964f179690d10510378958 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- JAK-STAT
-
Jak nas widzą…
por: Zuzanna Łopacińska‑Piędel
Publicado: (2021) -
Jak badać politykę?
por: Marek Pająk
Publicado: (2014) -
Treatment and management of myelofibrosis in the era of JAK inhibitors
por: Keohane C, et al.
Publicado: (2013) -
Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]
por: Keohane C, et al.
Publicado: (2013)